Yujie Wang Selected Research

qizhen

6/2021

Qizhen capsule inhibits colorectal cancer by inducing NAG-1/GDF15 expression that mediated via MAPK/ERK activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yujie Wang Research Topics

Disease

51	Neoplasms (Cancer) 06/2022 - 09/2012
11	Inflammation (Inflammations) 03/2022 - 01/2015
11	Infections 01/2022 - 01/2017
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
10	Breast Neoplasms (Breast Cancer) 02/2021 - 03/2015
8	Stroke (Strokes) 01/2022 - 11/2011
8	Ischemic Stroke 07/2021 - 11/2011
7	Head and Neck Neoplasms (Head and Neck Cancer) 04/2022 - 02/2020
7	Nasopharyngeal Carcinoma 01/2022 - 10/2018
6	Carcinogenesis 09/2021 - 01/2012
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2013
5	Body Weight (Weight, Body) 12/2021 - 02/2014
5	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 01/2016
5	Myocardial Infarction 01/2021 - 09/2010
4	Pain (Aches) 01/2022 - 09/2018
4	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 11/2019
4	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2012
4	Hypoxia (Hypoxemia) 05/2019 - 04/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2013
4	Heart Failure 02/2014 - 01/2011
4	Heart Valve Diseases (Valvular Heart Disease) 02/2013 - 09/2010
3	Melanoma (Melanoma, Malignant) 06/2022 - 07/2020
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 11/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 12/2015
3	Endotoxemia 09/2021 - 05/2018
3	Atherosclerosis 01/2021 - 01/2015
3	Hypertension (High Blood Pressure) 03/2016 - 05/2012
3	Hemorrhagic Stroke 10/2012 - 11/2011
2	Pathologic Constriction (Stenosis) 09/2022 - 01/2018
2	Obesity 06/2022 - 03/2021
2	Atrophy 06/2022 - 06/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022 - 01/2015
2	Liver Diseases (Liver Disease) 03/2022 - 01/2021
2	Fibrosis (Cirrhosis) 03/2022 - 01/2015
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2021
2	Atrial Fibrillation 01/2022 - 10/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2022
2	Liver Neoplasms (Liver Cancer) 01/2022 - 09/2021
2	Cerebellar Ataxia (Dysmetria) 12/2021 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 11/2020
2	Dysbiosis 09/2021 - 03/2021
2	Fatigue 07/2021 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 06/2021 - 08/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2020
2	Lung Diseases (Lung Disease) 01/2021 - 09/2010
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 05/2020
2	HIV Infections (HIV Infection) 11/2020 - 04/2018

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2012
15	Pharmaceutical PreparationsIBA 01/2022 - 08/2011
14	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2015
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2014
8	CholesterolIBA 11/2021 - 09/2010
8	MicroRNAs (MicroRNA)IBA 09/2021 - 03/2017
6	CytokinesIBA 03/2022 - 05/2018
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
6	Antihypertensive Agents (Antihypertensives)IBA 02/2014 - 09/2010
4	LipidsIBA 03/2022 - 01/2020
4	AcidsIBA 03/2022 - 10/2020
4	Circular RNAIBA 01/2022 - 01/2020
4	Insulin (Novolin)FDA Link 01/2022 - 01/2019
4	Biological ProductsIBA 01/2022 - 01/2018
4	Polysaccharides (Glycans)IBA 09/2021 - 12/2018
4	Small Interfering RNA (siRNA)IBA 02/2021 - 11/2015
4	Estrogen ReceptorsIBA 01/2020 - 04/2015
3	Contrast MediaIBA 03/2022 - 09/2012
3	Hormones (Hormone)IBA 12/2021 - 01/2019
3	LipopolysaccharidesIBA 09/2021 - 05/2018
3	Therapeutic UsesIBA 06/2021 - 10/2019
3	EnzymesIBA 01/2021 - 05/2018
3	HDL CholesterolIBA 12/2014 - 07/2012
2	ChromatinIBA 06/2022 - 01/2020
2	AntioxidantsIBA 05/2022 - 07/2015
2	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2022 - 11/2021
2	HDL LipoproteinsIBA 04/2022 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2017
2	GoldIBA 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 12/2021
2	LeptinIBA 01/2022 - 11/2019
2	CXC ChemokinesIBA 01/2022 - 12/2021
2	CreatinineIBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2021
2	SteroidsIBA 12/2021 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2019
2	PrebioticsIBA 09/2021 - 03/2021
2	Volatile Fatty AcidsIBA 09/2021 - 03/2021
2	Taxoids (Taxanes)IBA 07/2021 - 08/2018
2	Caspase 3 (Caspase-3)IBA 06/2021 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2020

Therapy/Procedure

30	Therapeutics 03/2022 - 10/2014
12	Radiotherapy 04/2022 - 10/2014
10	Drug Therapy (Chemotherapy) 07/2021 - 04/2015
4	Chemoradiotherapy 07/2021 - 01/2019
4	Neoadjuvant Therapy 01/2020 - 10/2015
3	Immunotherapy 01/2022 - 02/2021
3	Thrombectomy 07/2021 - 09/2020
2	Stents 09/2022 - 01/2021